Perrigo says Omega takes it into global top five

2 April 2015 - Deborah Wilkes

Archived

Perrigo has completed the acquisition of Belgian OTC specialist Omega Pharma in a cash and shares transaction worth around €3.8 billion (US$4.2 billion) including the assumption of €1.3 billion in debt. Joseph Papa – Perrigo's chairman, president and chief executive officer – said the deal created "a top five global OTC healthcare company by revenue".

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: